Drug merger expected to be worth $70B
Article Abstract:
Warner-Lambert Co's merger with American Home Products Corp is projected to be worth over $70 billion, so far the biggest transaction to occur in a rapidly merging drug industry. The new company, to be named American Warner, will be ranked as the No. 2 pharmaceutical company in the world with annual revenue of nearly $24 million. The deal requires the approval of both companies' board of directors as well as approval by shareholders and regulatory agencies.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Warner-Lambert uses Lipitor in Pfizer fight
Article Abstract:
Warner-Lambert of Morris Plains, NJ, is trying to fend off Pfizer's hostile takeover bid by threatening to pull out of an agreement to jointly market Warner-Lambert's blockbuster cholesterol drug Lipitor. Pfizer derives about 40% of its annual profit from Lipitor, which was launched in 1997 and generates annual sales of $4 billion. By issuing the threat, observers say Warner-Lambert wants to exert more downward pressure on Pfizer's stock, which it is using for its hostile bid.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Domtar suspends dividend in wake of worse-than-expected quarter. Transat profit plunges in quarter
- Abstracts: Temp workers at Microsoft win lawsuit; benefits were denied to more than 8,000
- Abstracts: Vivendi, Seagram, CanalPlus seal deal; investors uneasy. Some find Seagram CEO's strategy hard to pinpoint. Where will media's new king take us?
- Abstracts: New markets pose challenge for enforcement of breakup. Microsoft responds to judge's findings. Breakup hangs over Microsoft stock
- Abstracts: Drug merger turns into tense triangle. Drug firms polish merger. $80 billion drug merger talks back on